A.P. Nonweiler, Co., a portfolio company of Renovo Capital, acquired Vortex Coatings Inc. (PurEpoxy), a Canadian manufacturer specializing in concrete coatings systems for residential and commercial applications.

Transaction overview

On September 6, 2022, A.P. Nonweiler, Co. announced the acquisition of PurEpoxy to expand its concrete coatings product offering. The deal's financial details were not disclosed. This marks APN’s first add-on acquisition since Renovo Capital invested in March 2022.

Deal structure and financing

Details on the equity/debt split, lead banks, leverage metrics, and lock-up terms are unavailable as of this writing. PurEpoxy founder Erik Gravel retained no stake in the transaction; however, there was mention of future growth potential with APN’s support. The announcement did not specify IPO optionality or any seller-employee lock-ups.

Strategic context

APN's acquisition aims to bolster its concrete coatings portfolio and tap into PurEpoxy's distribution network globally. Mark Nonweiler highlighted the synergy between APN's 75-year history of developing custom coating solutions and Erik Gravel’s product line, emphasizing R&D capabilities for innovation in new products.

PurEpoxy benefits from APN’s manufacturing capacity across two sites to meet growing customer demands more efficiently. The acquisition also aligns with Renovo Capital's strategy to invest in technical businesses that can generate significant value through operational improvements and strategic initiatives.

Regulatory path

There is no information on regulatory scrutiny or filings for this transaction as of the close date. Given APN’s U.S. location and PurEpoxy’s Canadian base, it is likely that both U.S. (FTC) and Canadian regulators reviewed the deal. No antitrust remedies were mentioned in the announcement.

The transaction’s size relative to industry standards did not trigger significant regulatory hurdles or public filings such as HSR notifications in the United States or EU merger control requirements. The timeline for regulatory approvals was not disclosed, but the deal closed on September 6, indicating a smooth process without notable delays due to regulatory concerns.